002727 Stock Overview
Together with its subsidiary, operates a chain of drugstores in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Yixintang Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.96 |
| 52 Week High | CN¥26.45 |
| 52 Week Low | CN¥11.18 |
| Beta | 0.34 |
| 11 Month Change | -8.70% |
| 3 Month Change | -31.19% |
| 1 Year Change | -48.85% |
| 33 Year Change | -58.15% |
| 5 Year Change | -50.25% |
| Change since IPO | -44.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002727 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | 2.3% | 6.0% | -1.4% |
| 1Y | -48.8% | -34.6% | -21.4% |
Return vs Industry: 002727 underperformed the CN Consumer Retailing industry which returned -34.6% over the past year.
Return vs Market: 002727 underperformed the CN Market which returned -21.4% over the past year.
Price Volatility
| 002727 volatility | |
|---|---|
| 002727 Average Weekly Movement | 4.9% |
| Consumer Retailing Industry Average Movement | 5.3% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 002727's share price has been volatile over the past 3 months.
Volatility Over Time: 002727's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 35,024 | Hong Xian Ruan | www.hx8886.com |
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. It operates stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities.
Yixintang Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 002727 fundamental statistics | |
|---|---|
| Market cap | CN¥7.13b |
| Earnings (TTM) | CN¥326.77m |
| Revenue (TTM) | CN¥18.01b |
21.2x
P/E Ratio0.4x
P/S RatioIs 002727 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002727 income statement (TTM) | |
|---|---|
| Revenue | CN¥18.01b |
| Cost of Revenue | CN¥12.43b |
| Gross Profit | CN¥5.58b |
| Other Expenses | CN¥5.25b |
| Earnings | CN¥326.77m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 30.97% |
| Net Profit Margin | 1.81% |
| Debt/Equity Ratio | 6.5% |
How did 002727 perform over the long term?
See historical performance and comparison